Logo wahanariau.com
  2. Aavantgarde

Aavantgarde

Index
Globenewswire

AAVantgarde Announces FDA Orphan Drug Designation and UK CTA approval for AAVB-039 for the Treatment of Stargardt Disease

Kamis, 02 Oktober 2025 - 21:02:36 Wib
Globenewswire

AAVantgarde Presents Updated Positive Clinical Data From its AAVB-081 Program for Usher 1B at EURetina 2025

Jumat, 05 September 2025 - 20:46:23 Wib
Globenewswire

AAVantgarde to Present Updated Clinical Data from LUCE-1 Study at EURetina 2025

Kamis, 28 Agustus 2025 - 22:08:34 Wib
Globenewswire

AAVantgarde Bio Announces FDA Fast Track Designation for AAVB-039 for the Treatment of Stargardt Disease

Rabu, 13 Agustus 2025 - 19:43:11 Wib
Globenewswire

AAVantgarde Receives FDA Clearance to Progress Stargardt Disease Asset, AAVB-039, into CELESTE, a Phase 1/2 Clinical Trial

Rabu, 16 Juli 2025 - 01:29:28 Wib
Globenewswire

AAVantgarde Presents Positive Clinical Data From its AAVB-081 Program for Usher 1B and Preclinical Data From its AAVB-039 Program for Stargardt at the ARVO 2025 Annual Meeting

Selasa, 13 Mei 2025 - 00:58:41 Wib
Globenewswire

AAVantgarde appoints Mr. Rasmus Holm-Jorgensen as Chief Financial Officer

Selasa, 29 April 2025 - 03:01:58 Wib